As shown in Table 1 , inhibitors or antagonists of these targets have shown good results in animals, such as CXCR3, CXCR4, CXCL10, CXCL12, and CXCL13, especially the antibody of CXCL10 (MDX-1100) has entered clinical trials (25) ( Figure 2 )
Synaptic and nonsynaptic localization of GABA A receptors containing the 5 subunit in the rat brain
The trials look to find new ways to prevent, detect, or treat disease and improve quality of life
This is also in line with a previous report showing that TAX6 can cellautonomously control adaptation in a number of sensory neurons and modalities (e.g., the thermosensory AFD neurons, the polymodal ASH neurons, and in the olfactory AWC neurons
Late Friday evening the US FDA issued an emergency use authorization (EUA) for the second vaccine for SARS-CoV-2, this one from Moderna Inc
Melittin from Apis florea venom as a promising therapeutic agent for skin cancer treatment